🟢 HCW Biologics is trading 5% up in after-hours trading

HCW Biologics is trading at $1.23, up 5.13%, with no confirmed company-specific catalyst identified for the after-hours rise.

• Shares closed the regular session at $1.17, down 7.14%.
• Its latest listed release was October 9, about progress on its T-cell engager IND application.
• Broader markets fell after hotter-than-expected inflation, which does not explain this opposite-direction after-hours move. A stock site reported a “news pending” trading halt, but no corroborating company announcement was found; the report is unconfirmed.